Article content continued

Photo by Chris Procaylo / Postmedia News

An investigation found Bonify had 200 kilograms of cannabis product that was not authorized for sale.

Following the investigation, Bonify turned over all operational control to RavenQuest Technologies until it can meet all of its compliance requirements.

Robinson said the company likely promised to provide more pot than it could produce before legalization in October, leading to poor choices trying to meet Bonify’s supply agreements.

“What they did was not at all remotely close to following the regulations,” he said.

Most of the unauthorized pot was not shipped to stores, but 52 3.5-gram bag units sold in Saskatchewan in November were not recovered during the recall.

While there have been no complaints, Robinson said the products may not meet some of the microbial and chemical contaminant limits specified by federal cannabis regulations. Some testing of the pot showed an unconfirmed presence of E. coli.

The investigation did not discover where the unauthorized cannabis came from. Robinson said the findings have been provided, with names redacted, to Manitoba and federal regulators.

Photo by JOHN WOODS / THE CANADIAN PRESS

Manitoba suspended Bonify’s operations last week. At the time, Premier Brian Pallister said some illegal cannabis had entered the legal distribution system.

Pallister said there was a lack of communication from Health Canada about that recall, and called it a “black day” for the legal cannabis system.

Federal Organized Crime Reduction Minister Bill Blair has said he is aware of the allegations surrounding Bonify and is working with Manitoba to “displace the illicit market.”

Health Canada spokesman Eric Morrissette said the department is still determining whether the law was broken.

Robinson said he expects it will take weeks before Bonify starts distributing medicinal marijuana again and months before the company re-enters the larger retail market.

On Christmas Eve, the company faced another round of recalls — this time due to either record-keeping or labelling issues.

Health Canada said approximately 5,883 units of recalled product were sold between Oct. 22 and Dec. 20, 2018.